Bijan Ahvazi

Array ( [id] => 8962945 [patent_doc_number] => 20130202547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'Ophthalmic Compositions Containing Diglycine' [patent_app_type] => utility [patent_app_number] => 13/366398 [patent_app_country] => US [patent_app_date] => 2012-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6023 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13366398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162093 [patent_doc_number] => 20130310370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'DRUG THERAPY FOR PREVENTING OR TREATING GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/983720 [patent_app_country] => US [patent_app_date] => 2012-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3559 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173662 [patent_doc_number] => 20120108557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/349688 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4720 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108557.pdf [firstpage_image] =>[orig_patent_app_number] => 13349688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186728 [patent_doc_number] => 20120115870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'CONTROL OF INTRAOCULAR PRESSURE USING ALK5 MODULATION AGENTS' [patent_app_type] => utility [patent_app_number] => 13/348376 [patent_app_country] => US [patent_app_date] => 2012-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5050 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115870.pdf [firstpage_image] =>[orig_patent_app_number] => 13348376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9082014 [patent_doc_number] => 20130267544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'Use of LP-PLA2 Inhibitors in the Treatment and Prevention of Eye Diseases' [patent_app_type] => utility [patent_app_number] => 13/992789 [patent_app_country] => US [patent_app_date] => 2011-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 31030 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9095021 [patent_doc_number] => 20130274332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'OPHTHALMIC COMPOSITION FOR CONTACT LENS' [patent_app_type] => utility [patent_app_number] => 13/993925 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10370 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140821 [patent_doc_number] => 20120094962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY' [patent_app_type] => utility [patent_app_number] => 13/315397 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6209 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094962.pdf [firstpage_image] =>[orig_patent_app_number] => 13315397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128375 [patent_doc_number] => 20120088739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'METHOD FOR TREATING MEIBOMIAN GLAND DISEASE' [patent_app_type] => utility [patent_app_number] => 13/309145 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5382 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088739.pdf [firstpage_image] =>[orig_patent_app_number] => 13309145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760177 [patent_doc_number] => 08420699 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-04-16 [patent_title] => 'Composition and methods of treatment using deionized and ozonated solution' [patent_app_type] => utility [patent_app_number] => 13/286213 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10433 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766320 [patent_doc_number] => 20120034278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'OPHTHALMIC PREPARATION CONTAINING MENTHYL ESTER OF INDOMETHACIN' [patent_app_type] => utility [patent_app_number] => 13/273404 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4350 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034278.pdf [firstpage_image] =>[orig_patent_app_number] => 13273404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128513 [patent_doc_number] => 20120088804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/270004 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6038 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088804.pdf [firstpage_image] =>[orig_patent_app_number] => 13270004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9569857 [patent_doc_number] => 20140187570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'NOVEL FORMULATIONS OF PYRIMETHANIL, AND THEIR USE IN TREATMENT OF CROPS' [patent_app_type] => utility [patent_app_number] => 13/824664 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2872 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10175938 [patent_doc_number] => 09206129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Agent for treatment of eye diseases' [patent_app_type] => utility [patent_app_number] => 13/876596 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 30 [patent_no_of_words] => 28076 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511954 [patent_doc_number] => 20140148446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'COMPOUNDS THAT ENABLE ALTERNATIVE MITOCHONDRIAL ELECTRON TRANSFER' [patent_app_type] => utility [patent_app_number] => 13/825819 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756816 [patent_doc_number] => 20120028947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Ophthalmic Compositions' [patent_app_type] => utility [patent_app_number] => 13/239612 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8396 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028947.pdf [firstpage_image] =>[orig_patent_app_number] => 13239612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733688 [patent_doc_number] => 20120016001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'SUCCINIMIDE DERIVATIVES AS OCULAR HYPOTENSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/226176 [patent_app_country] => US [patent_app_date] => 2011-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6022 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20120016001.pdf [firstpage_image] =>[orig_patent_app_number] => 13226176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108288 [patent_doc_number] => 20130281420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'Ophthalmic Formulations of Squalamine' [patent_app_type] => utility [patent_app_number] => 13/817306 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7144 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13817306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580885 [patent_doc_number] => 20110294768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Ophthalmic Suspension for Ocular Use' [patent_app_type] => utility [patent_app_number] => 13/205785 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4947 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294768.pdf [firstpage_image] =>[orig_patent_app_number] => 13205785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7737138 [patent_doc_number] => 20120017806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Ophthalmic and Contact Lens Solutions Using Low Molecular Weight Amines' [patent_app_type] => utility [patent_app_number] => 13/195389 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4318 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20120017806.pdf [firstpage_image] =>[orig_patent_app_number] => 13195389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511964 [patent_doc_number] => 20140148456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'PRESERVATIVE FREE BRIMONIDINE AND TIMOLOL SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/812599 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1029 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812599 [rel_patent_id] =>[rel_patent_doc_number] =>)